iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025)
iSpecimen (ISPC) posted quarterly Cash from Financing Activities of $5.0 million for Q4 2025, up 32.94% year-over-year from $3.8 million in Q4 2024, and down 4.1% quarter-over-quarter from $5.2 million in Q3 2025.
iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025) Analysis & Trends
iSpecimen's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $5.0 million for Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 32.94% year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $14.9 million (up 155.66% YoY), while the FY2025 annual figure was $10.2 million, up 76.04% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $5.0 million, down from $5.2 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $19.6 million in Q4 2021, with the low at -$3.5 million in Q4 2022.
- The 5-year median for Cash from Financing Activities is $467628.5 (2022), against an average of $2.5 million.
- Peak annual rise in Cash from Financing Activities reached 41304.5% in 2024, while the deepest fall reached 275.47% in 2024.
- iSpecimen's Cash from Financing Activities stood at $19.6 million in 2021, then sank by 117.88% to -$3.5 million in 2022, then jumped by 100.09% to $3153.0 in 2023, then soared by 119541.45% to $3.8 million in 2024, then jumped by 32.94% to $5.0 million in 2025.
- Business Quant data shows ISPC's Cash from Financing Activities at $5.0 million in Q4 2025, $5.2 million in Q3 2025, and $3.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 859,980.00 |
| Sep 30, 2024 | 859,980.00 |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | -118,858.00 |
| Mar 31, 2024 | -118,858.00 |
| Jun 30, 2023 | 3,153.00 |
| Jun 30, 2023 | 3,153.00 |
| Mar 31, 2023 | 67,736.00 |
| Mar 31, 2023 | 67,736.00 |
| Dec 31, 2022 | -3.50 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | -4,967.00 |
| Sep 30, 2022 | -4,967.00 |